Verified stock metrics
Nurix Therapeutics Key Stock Metrics
Direct answer
Nurix Therapeutics has 9 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked November 4, 2026.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $2.82B
- P/E ratio
- 10.63x
- Price-to-book ratio
- 2.91x
- Return on equity
- 43.99%
- Dividend yield
- 0%
- 52-week price range
- $11.67 to $28.23
- Revenue growth
- 8,426.3%
- Profit margin
- 42.01%
- Debt-to-equity ratio
- 6.75%
Explore related company data
View Nurix Therapeutics's market capitalizationView Nurix Therapeutics's p/e ratioView Nurix Therapeutics's price-to-book ratioView Nurix Therapeutics's return on equityView Nurix Therapeutics's dividend yieldView Nurix Therapeutics's 52-week price rangeView Nurix Therapeutics's revenue growthView Nurix Therapeutics's profit marginView Nurix Therapeutics's debt-to-equity ratioReturn to Nurix Therapeutics profile